Literature DB >> 26052452

A Historical Tale of Two Lymphomas: Part I: Hodgkin lymphoma.

Ritu Lakhtakia1, Ikram Burney2.   

Abstract

Entities:  

Year:  2015        PMID： 26052452      PMCID： PMC4450782     

Source DB:  PubMed          Journal:  Sultan Qaboos Univ Med J        ISSN： 2075-051X


× No keyword cloud information.
  29 in total

1.  Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.

Authors:  L S GOODMAN; M M WINTROBE
Journal:  J Am Med Assoc       Date:  1946-09-21

2.  FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma.

Authors:  Martin Hutchings; Annika Loft; Mads Hansen; Lars Møller Pedersen; Thora Buhl; Jesper Jurlander; Simon Buus; Susanne Keiding; Francesco D'Amore; Anne-Marie Boesen; Anne Kiil Berthelsen; Lena Specht
Journal:  Blood       Date:  2005-09-08       Impact factor: 22.113

3.  On some Morbid Appearances of the Absorbent Glands and Spleen.

Authors: 
Journal:  Med Chir Trans       Date:  1832

4.  Combination chemotherapy in the treatment of advanced Hodgkin's disease.

Authors:  V T Devita; A A Serpick; P P Carbone
Journal:  Ann Intern Med       Date:  1970-12       Impact factor: 25.391

5.  Thomas hodgkin remembered

Authors: 
Journal:  Cancer Treat Rev       Date:  1999-06       Impact factor: 12.111

Review 6.  Shades of gray between large B-cell lymphomas and Hodgkin lymphomas: differential diagnosis and biological implications.

Authors:  Nancy L Harris
Journal:  Mod Pathol       Date:  2013-01       Impact factor: 7.842

Review 7.  BEACOPP: a new regimen for advanced Hodgkin's disease. German Hodgkin's Lymphoma Study Group.

Authors:  V Diehl; J Franklin; D Hasenclever; H Tesch; M Pfreundschuh; B Lathan; U Paulus; M Sieber; J U Rüffer; M Sextro; A Engert; J Wolf; R Hermann; L Holmer; U Stappert-Jahn; E Winnerlein-Trump; G Wulf; S Krause; A Glunz; K von Kalle; H Bischoff; C Haedicke; E Dühmke; A Georgii; M Loeffler
Journal:  Ann Oncol       Date:  1998       Impact factor: 32.976

Review 8.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.

Authors:  N L Harris; E S Jaffe; H Stein; P M Banks; J K Chan; M L Cleary; G Delsol; C De Wolf-Peeters; B Falini; K C Gatter
Journal:  Blood       Date:  1994-09-01       Impact factor: 22.113

9.  Curability of advanced Hodgkin's disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.

Authors:  V T DeVita; R M Simon; S M Hubbard; R C Young; C W Berard; J H Moxley; E Frei; P P Carbone; G P Canellos
Journal:  Ann Intern Med       Date:  1980-05       Impact factor: 25.391

10.  Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups.

Authors:  Claudia Allemani; Milena Sant; Roberta De Angelis; Rafael Marcos-Gragera; Jan Willem Coebergh
Journal:  Cancer       Date:  2006-07-15       Impact factor: 6.860
View more
  1 in total

1.  A Historical Tale of Two Lymphomas: Part II: Non-Hodgkin lymphoma.

Authors:  Ritu Lakhtakia; Ikram Burney
Journal:  Sultan Qaboos Univ Med J       Date:  2015-08-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.